Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oncologic Applications of Positron Emission Tomography (PET) Scanning | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oncologic Applications of Photodynamic Therapy, Including Barrett Esophagus | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ocriplasmin for Symptomatic Vitreomacular Adhesion | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Occlusion of Uterine Arteries Using Transcatheter Embolization | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Occipital Nerve Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nuzyra (omadacycline) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nutrient/Nutritional Panel Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nuplazid (pimavanserin) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nuedexta (dextromethorphan and quinidine) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | NSAIDs | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Noxafil/Vfend | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Noritate 1% (metronidazole cream) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nonmyeloablative Allogeneic Transplants of Hematopoietic Stem-Cells for Treatment of Malignancy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Noninvasive Prenatal Screening for Fetal Aneuploidies, Microdeletions, Single-Gene Disorders, and Twin Zygosity Using Cell-Free Fetal DNA | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Non-Pharmacologic Treatment of Rosacea | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Non-Pedicle Supplemental Fixation Device for Use in the Non-Cervical Spine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Non-Invasive Measurement of Left Ventricular End Diastolic Pressure (LVEDP) in the Outpatient Setting | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Non-Contact Ultrasound Treatment for Wounds | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nitisinone | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Niktimvo (axatilimab-csfr) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Next-Generation Sequencing for the Assessment of Measurable Residual Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | New Drug Approvals and Newly Approved Indications for Currently Available Medications | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Neuromuscular Electrical Stimulation (NMES) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Neurofeedback | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Neural Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nerve Graft With Radical Prostatectomy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nerve Fiber Density Measurement | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Neonatal Fc Receptor Blockers | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Negative Pressure Wound Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Needle-Free Insulin Injection Systems | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Navigated Transcranial Magnetic Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Natroba (spinosad) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Myoelectric Prosthetic and Orthotic Components for the Upper Limb | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Myocardial Sympathetic Innervation Imaging in Individuals with Heart Failure | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Myocardial Strain Imaging | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Myeloperoxidase (MPO) Immunoassay for Cardiac Disease Risk | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multitarget Polymerase Chain Reaction Testing for Diagnosis of Bacterial Vaginosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multispectral Digital Skin Lesion Analysis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multiple Sclerosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multimarker Serum Testing Related to Ovarian Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multicancer Early Detection Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multibiomarker Disease Activity Blood Test for Rheumatoid Arthritis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multianalyte Assays with Algorithmic Analyses for Predicting Risk of Type 2 Diabetes | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Motorized Wheelchairs | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Morbid Obesity | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Monoclonal Antibody Therapies for Migraine Prevention | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Monoclonal Antibodies for Treatment of Alzheimer’s Disease | New policy |